The global cryptococcosis market size was significantly robust in 2022 and is expected to register a steady revenue CAGR over the forecast period. Increasing incidence of deadly fungal disease, rising awareness regarding treatment, and high occurrence of disease in HIV patients in their final stages are some key factors expected to drive market revenue growth during the forecast period. Several governments and non-governmental organizations are taking steps to create awareness about cryptococcosis, which is a disseminated or pulmonary infection contracted by inhaling soil contaminated with encapsulated yeasts such as Cryptococcus neoformans. Rising adoption of pulmonary route as an alternative to oral and parenteral delivery techniques is one of the factor supporting growth of the market going ahead.
Increasing number of people suffering from fungal ailments is one of the factors driving revenue growth of global cryptococcosis market. In Africa, cryptococcosis is believed to be the next basic AIDS-defining sickness. Patients on long-term corticosteroid therapy as well as those suffering from certain conditions of lymphoma such as Hodgkin\’s lymphoma, liver cirrhosis, sarcoidosis are associated with an increased risk. Rising prevalence of HIV-related cryptococcosis infection as well as supportive activities by government and non-government organizations to raise awareness of available treatment options are some key factors driving revenue growth going ahead.
Request a Sample@ https://www.qyresearchmedical.com/sample/119458
Limited information about distribution of pulmonary medicines is a major restraining factor that could negatively impact growth of the global market. In add
ition, increasing number of generic drugs, patients with a high fatality rate, patent expiry, lack of skilled technicians are other key factors restraining cryptococcosis market revenue growth to some extent.
COVID-19 Impact Analysis
- The virus outbreak and social distancing norms and restrictions severely disrupted the overall business landscape and operations worldwide.
- COVID-19 pandemic and lockdowns have resulted in several countries shutting down airports, ports, and commercial and domestic transportation. This had impacted manufacturing activities and operations globally and took a toll on the economy of various countries.
- Sudden and drastic downturn in economic activity caused a slowdown in manufacturing, production, agriculture, fisheries, dairy, and other sectors and also resulted in employment loss to a major extent.
- Supply impacts were further compounded due to challenges on the demand-side owing to reduced disposable income, depleting savings, and increased concerns and uncertainties.
- Emergence of variants of the virus and rise in infection rates during the initial waves and subsequent lockdowns has severely impacted operations and disrupted supply chains.
Based on type, the cryptococcosis market is segmented into amphotericin B, flucytosine, fluconazole, and others. The amphotericin B segment accounted for largest revenue share compared to other type segments in 2020, driven by rising cases of fungal infections, increasing awareness regarding usage of medications prescribed by healthcare professional, and government initiatives to treat fungal disorders are some key factors driving revenue growth of this segment.
Distribution Channel Outlook:
Based on distribution channel, the cryptococcosis market is segmented into hospital pharmacies, retail pharmacies, drug store, mail order pharmacies, and others. The hospital pharmacies segment accounted for robust revenue share among other distribution channel segments in 2020. Factors such as availability of fungal medications and rising healthcare spending globally are expected to support revenue growth of this segment going ahead.
North America market is expected to account for a substantially larger revenue share during the forecast period. Recent advancements in cryptococcosis diagnostics, including biomarker tests, favorable reimbursement policies for disease screening, and greater access to antifungal medications like flucytosine as well as improved access to antifungal drugs are some key factors positively impact growth of the market in this region. In addition, rising prevalence of HIV prevalence and presence of well-structured healthcare business are other factors attributable to rapid revenue growth.
Middle East and Africa is expected to register a significant steady revenue share due to increasing incidence of HIV-related cryptococcosis infections and rising need for advanced treatment facilities.
Companies profiled in the market report
Some major players in the global cryptococcosis market are Bristol-Myers Squibb Company, Janssen Biotech, Inc. (Johnson & Johnson), Abbott Laboratories, Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Sigmapharm Laboratories LLC.
Major companies are adopting various strategies, including mergers, acquisitions, partnerships, and new product development, among others to stay ahead of the competition and expand market footprint and revenue share.
Segments covered in the report:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2023 to 2032. The global cryptococcosis market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global cryptococcosis market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
For the purpose of this report has segmented the global cryptococcosis market on the basis of type, distribution channel, and region:
Type Outlook (Revenue, USD Billion; 2023 – 2032)
- Amphotericin B
- Others (Voriconazole, surgery treatment, etc.)
Distribution Channel Outlook (Revenue, USD Billion; 2023 – 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- Mail Order Pharmacies
Region Outlook (Revenue, USD Billion; 2023 – 2032)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119458/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: